Leila Shepherd
Imperial College London
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Leila Shepherd as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:46 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07112352 · Healthy Ageing: a Feasibility Study to Evaluate Digitally-enabled Ways to Support Healthy AgeingImperial College London · active not recruiting · Frailty, Older Adults (65 Years and Older), Digital Health Intervention · principal investigator
- N/ANCT06526637 · User Testing of an End of Life Medication Support Intervention for Lay Carers (Palliate).Imperial College London · completed · End of Life, Support, Family · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:46 UTC. The ranking covers the 200 most relevant of 133 PubMed records, and a shared surname and initials can bring in a namesake. All 133 on PubMed
- K-ras mutations and benefit from cetuximab in advanced colorectal cancer.N Engl J Med · 20082,963 citationsRCR 65.1
- Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.N Engl J Med · 20031,717 citationsRCR 33.9
- A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.N Engl J Med · 20031,384 citationsRCR 30.7
- All-trans-retinoic acid in acute promyelocytic leukemia.N Engl J Med · 1997841 citationsRCR 17.5
- Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.J Natl Cancer Inst · 2005835 citationsRCR 17.9
- Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.N Engl J Med · 2000780 citationsRCR 15.9
- 660 citationsRCR 16.6
- 415 citationsRCR 10.8
- HER2 and responsiveness of breast cancer to adjuvant chemotherapy.N Engl J Med · 2006390 citationsRCR 8.6
- 383 citationsRCR 10.6